Literature DB >> 11781342

Killing the messenger: new insights into nonsense-mediated mRNA decay.

Peter H Byers1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11781342      PMCID： PMC150830          DOI： 10.1172/JCI14841

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

1.  Purification and characterization of human RNPS1: a general activator of pre-mRNA splicing.

Authors:  A Mayeda; J Badolato; R Kobayashi; M Q Zhang; E M Gardiner; A R Krainer
Journal:  EMBO J       Date:  1999-08-16       Impact factor: 11.598

2.  Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation.

Authors:  U Schwarze; B J Starman; P H Byers
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

3.  Pre-mRNA splicing imprints mRNA in the nucleus with a novel RNA-binding protein that persists in the cytoplasm.

Authors:  N Kataoka; J Yong; V N Kim; F Velazquez; R A Perkinson; F Wang; G Dreyfuss
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

4.  The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans.

Authors:  Z Zhou; M J Luo; K Straesser; J Katahira; E Hurt; R Reed
Journal:  Nature       Date:  2000-09-21       Impact factor: 49.962

5.  Characterization of the biochemical properties of the human Upf1 gene product that is involved in nonsense-mediated mRNA decay.

Authors:  A Bhattacharya; K Czaplinski; P Trifillis; F He; A Jacobson; S W Peltz
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

6.  A splicing-dependent regulatory mechanism that detects translation signals.

Authors:  M S Carter; S Li; M F Wilkinson
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

7.  Intron function in the nonsense-mediated decay of beta-globin mRNA: indications that pre-mRNA splicing in the nucleus can influence mRNA translation in the cytoplasm.

Authors:  J Zhang; X Sun; Y Qian; L E Maquat
Journal:  RNA       Date:  1998-07       Impact factor: 4.942

8.  A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro.

Authors:  M S Carter; J Doskow; P Morris; S Li; R P Nhim; S Sandstedt; M F Wilkinson
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

9.  The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes.

Authors:  T McGarvey; E Rosonina; S McCracken; Q Li; R Arnaout; E Mientjes; J A Nickerson; D Awrey; J Greenblatt; G Grosveld; B J Blencowe
Journal:  J Cell Biol       Date:  2000-07-24       Impact factor: 10.539

10.  Tracking COL1A1 RNA in osteogenesis imperfecta. splice-defective transcripts initiate transport from the gene but are retained within the SC35 domain.

Authors:  C Johnson; D Primorac; M McKinstry; J McNeil; D Rowe; J B Lawrence
Journal:  J Cell Biol       Date:  2000-08-07       Impact factor: 10.539
View more
  40 in total

Review 1.  Transcription factor haploinsufficiency: when half a loaf is not enough.

Authors:  J G Seidman; Christine Seidman
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 2.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  A novel splicing mutation of the alpha-spectrin gene in the original hereditary pyropoikilocytosis kindred.

Authors:  Daniel B Costa; Larisa Lozovatsky; Patrick G Gallagher; Bernard G Forget
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

4.  De novo deletions in the paired domain of PAX6 in south Indian aniridic patients.

Authors:  Guruswamy Neethirajan; J Martin Collinson; Subbaiah Ramasamy Krishnadas; Perumalsamy Vijayalakshmi; Shetty Shashikant; Chandrashekhar Reena; Periasamy Sundaresan
Journal:  J Hum Genet       Date:  2004-10-08       Impact factor: 3.172

5.  Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.

Authors:  Matthew M Hims; El Chérif Ibrahim; Maire Leyne; James Mull; Lijuan Liu; Conxi Lazaro; Ranjit S Shetty; Sandra Gill; James F Gusella; Robin Reed; Susan A Slaugenhaupt
Journal:  J Mol Med (Berl)       Date:  2007-01-06       Impact factor: 4.599

6.  Oxidative DNA damage and its repair in rat spleen following subchronic exposure to aniline.

Authors:  Huaxian Ma; Jianling Wang; Sherif Z Abdel-Rahman; Paul J Boor; M Firoze Khan
Journal:  Toxicol Appl Pharmacol       Date:  2008-08-22       Impact factor: 4.219

7.  Abnormal splicing of hepatocyte nuclear factor-1 beta in the renal cysts and diabetes syndrome.

Authors:  L W Harries; S Ellard; R W A Jones; A T Hattersley; C Bingham
Journal:  Diabetologia       Date:  2004-04-15       Impact factor: 10.122

Review 8.  B-cell and T-cell epitopes in anti-factor VIII immune responses.

Authors:  Kathleen P Pratt; Arthur R Thompson
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

9.  Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.

Authors:  Emmanuelle Jeannot; Lucille Mellottee; Paulette Bioulac-Sage; Charles Balabaud; Jean-Yves Scoazec; Jeanne Tran Van Nhieu; Yannick Bacq; Sophie Michalak; David Buob; Pierre Laurent-Puig; Ivan Rusyn; Jessica Zucman-Rossi
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

10.  PAX6 aniridia and interhemispheric brain anomalies.

Authors:  Hana Abouzeid; Mohamed A Youssef; Nihal ElShakankiri; Philippe Hauser; Francis L Munier; Daniel F Schorderet
Journal:  Mol Vis       Date:  2009-10-17       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.